Overall (N = 815) | Men (N = 628) | Women (N = 612) | P value | |
---|---|---|---|---|
Age (years) | 40.0 ± 9.7 | 41.5 ± 9.7 | 38.4 ± 10.1 | <0.001 |
Caucasian ethnicity | 457 (56.1) | 380 (60.5) | 312 (51.0) | <0.001 |
Years of formal education | 7.4 ± 4.1 | 8.0 ± 4.2 | 6.8 ± 3.8 | <0.001 |
Body mass index (kg/m2) | 24.6 ± 4.3 | 24.0 ± 3.5 | 25.3 ± 5.0 | <0.001 |
Time since HIV diagnosis (years) | 6.0 ± 4.2 | 6.3 ± 4.5 | 5.7 ± 3.9 | 0.03 |
CD4 (cells per μL) | 0.3 | |||
>350 | 451 (55.6) | 221 (53.0) | 230 (58.4) | |
200–350 | 215 (26.5) | 116 (27.8) | 99 (25.1) | |
<200 | 145 (17.9) | 80 (19.2) | 65 (16.5) | |
Viral load <50 copies/mL | 488 (60.3) | 261 (62.7) | 227 (57.8) | 0.15 |
Protease inhibitors use (PI) | 468 (37.7) | 212 (50.5) | 256 (64.8) | <0.001 |
Thymidine analogue nucleoside reverse transcriptase inhibitors (tNRTI) | 253 (31.0) | 131 (31.2) | 122 (30.9) | 0.9 |
Duration of PI (≥5 years) | 105 (12.9) | 61 (14.5) | 44 (11.1) | 0.15 |
Duration of tNRTI (≥4.5 years) | 255 (31.3) | 145 (34.5) | 110 (27.8) | 0.04 |